Literature DB >> 12394540

PRK-pTK as a treatment for a patient with Thygeson's superficial punctate keratopathy.

Michael H Goldstein1, Jonathan A Feistmann, M Tariq Bhatti.   

Abstract

PURPOSE: This article reports a case in which Thygeson's superficial punctate keratopathy was treated with photorefractive keratectomy (PRK) combined with phototherapeutic keratectomy (PTK).
METHODS: A 20-year-old white woman in good health who had a 2-year history of Thygeson's superficial punctate keratopathy in both eyes was evaluated for refractive surgery to treat myopia. The patient had experienced multiple recurrences of the Thygeson's during the preceding 2-year period. Previous treatment had consisted of topical steroids with good response to therapy but recurrences once the topical therapy was stopped. After discussing different options, the patient underwent uncomplicated PRK-PTK for treatment of her myopia, and her postoperative course was uneventful.
RESULTS: Eight months after undergoing PRK-PTK, the patient has excellent uncorrected visual acuity (20/20 in both eyes) and has experienced no recurrences of Thygeson's superficial punctate keratopathy.
CONCLUSIONS: Successful treatment of Thygeson's superficial punctate keratopathy in a patient with a low myopia may be achieved with the use of combined PRK-PTK procedures.

Entities:  

Mesh:

Year:  2002        PMID: 12394540     DOI: 10.1097/01.ICL.0000024359.29208.59

Source DB:  PubMed          Journal:  CLAO J        ISSN: 0733-8902


  3 in total

Review 1.  Phototherapeutic keratectomy.

Authors:  Varsha M Rathi; Sharadini P Vyas; Virender S Sangwan
Journal:  Indian J Ophthalmol       Date:  2012 Jan-Feb       Impact factor: 1.848

Review 2.  Thygeson's superficial punctate keratitis (TSPK): a paediatric case report and review of the literature.

Authors:  Xiao-Jiao Tang; Qing Liu; Lian-Hong Pi; Xin-Ke Chen; Lin Chen
Journal:  BMC Ophthalmol       Date:  2021-01-29       Impact factor: 2.209

Review 3.  Thygeson's superficial punctate keratopathy: A review and case series.

Authors:  Smruti Rekha Priyadarshini; Aravind Roy; Sujata Das
Journal:  Indian J Ophthalmol       Date:  2021-04       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.